Constante SJL, Méndez DA

Language: Spanish
References: 17
Page: 47-51
PDF size: 60.31 Kb.

ABSTRACT

Objective: To review the epidemiological profile of stroke associated to rheumatic heart disease (RHD) in a Mexican Cardiovascular Center. Cardioembolic stroke is one of the most severe causes of death and disability and the spectrum of its neurological complications is diverse. Patients and methods: This is a 10-years retrospective study of 709 patients with stroke diagnosis from the National Institute of Cardiology “Ignacio Chávez” Stroke Data Bank from 1991 to 2000. Derived from this information, only the cases with RHD were selected along with those with a perfectly defined profile for cardioembolic mechanism, according to the Cerebral Embolism Task Force on Cardiogenic Brain Embolism. Results: We selected 250 stroke patients; 163 of these cases (65.2%) presented cardioembolism criteria. This association was more frequent in women (126/77.3%) than in men (37/22.7%). Average age was of 50 years. The damage to valves in RHD was: DML with predominance of stenosis, 88/54%; MI, 56/34.3%; AVL, 19/11.7%. Atrial fibrillation was the most commonly associated arrhythmia. The presence of mechanical prosthetic mitral valves was of 59/36.19%. Sensor-motor syndrome and language disorders were the most common clinical neurological consequences. Conclusions: In our country, RHD continues being one of the most frequent causes of severe disability, specially when is associated to strokes in young people.

REFERENCES

1. KAPLAN E, MARKOWITZ M: The fall and rise of rheumatic fever in the United States: a commentary. Int J Cardiol 1988; 21: 3-10.

2. PADMAYATI S: Rheumatic fever and rheumatic heart disease in developing countries. Bull WHO 1978; 56: 543-50.

3. DAJANI AS: Fiebre reumática. En: Braunwald E. (ed). Tratado de Cardiología. Vol. 2. 5a Ed. México. Mc-Graw-Hill Interamericana Eds., 1999: 1937-43.

4. Cerebral Embolism Task Force. Cardiogenic Brain Embolism. Arch Neurol 1986; 43: 71-84.

5. The Second Report of the Cerebral Embolism Task Force. Cardiogenic Brain Embolism. Arch Neurol 1989; 46: 727-743.

6. CAMPANELLA N, DAHER W, PIRRI F, MOROSINI P: The probability of assessing the pathogenesis of ischemic stroke. Study of 81 patients. Rec Prog Med 2000; 91(2): 63-6.

7. EASTON JD, SHERMAN DG: Management of cerebral embolism of cardiac origin. Stroke 1980; 11: 443. Cita en Internet.

8. CHESEBRO JH, ADAMS PC, FUSTER V: Antitrombotic therapy in patients with valvular heart disease and prosthetic heart valves. J Am Coll Cardiol 1986; 8: 41B-56B.

9. COULSHED N, EPSTEIN EJ, MCKENDRICK CS, GALLOWAY RW, WALKER E: Systemic embolism in mitral valve disease. Br Heart J 1970; 32: 26-34.

10. SZEKELY P: Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Br Med J 1964; 1: 1209-1212.

11. WOLF PA, DAWBER TR, THOMAS HE JR., KANNEL WB: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978; 28: 973-977.

12. EDMUNDS LH: Thromboembolic complications of current cardiac prostheses. Ann Thorac Surg 1982; 34: 96-106.

13. MURPHY ES, KLOSTER FE: Late results of valve replacements surgery. Complications of prosthetic heart valves. Modern Concepts of Cardiovascular Disease 1979; XLVIII: 59-66.

14. DAMASIO H: A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol 1983; 40: 138-142.

15. FISHER CM: The posterior cerebral artery syndrome. Can J Neurol Sci 1986; 13: 232-239.

16. SOTO ME, CORDERA F, ESTRADA L, GUEL L, ABUD C, REYES PA: Fiebre reumática en el quinquenio 1994-1999 en dos hospitales en San Luis Potosí y en México D.F. Arch Cardiol Méx 2001; 71: 127-135.

17. DE GORTARI A, PELLÓN R, COSTERO I: Encefalopatía del reumático. Frecuencia insospechada de los accidentes cerebrales en el curso de la fiebre reumática y su papel como factores determinantes de la muerte en 107 casos con el estudio correspondiente de necropsia. Arch Inst Cardiol Mex 1947; 17(2): 193-223.